Nutrien (NTR)
(Delayed Data from NYSE)
$57.76 USD
+0.59 (1.03%)
Updated May 17, 2024 04:00 PM ET
After-Market: $57.77 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NTR 57.76 +0.59(1.03%)
Will NTR be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NTR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NTR
Intrepid Potash (IPI) Q1 Earnings Lag, Sales Beat Estimates
Nutrien's (NTR) Q1 Earnings and Revenues Surpass Estimates
NTR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Nutrien (NTR) Q1 Earnings: A Look at Key Metrics
Nutrien (NTR) Beats Q1 Earnings and Revenue Estimates
Wall Street's Insights Into Key Metrics Ahead of Nutrien (NTR) Q1 Earnings
Other News for NTR
Mizuho Securities downgrades Nutrien (NTR) to a Sell
Nutrien price target raised by $2 at Piper Sandler, here's why
Piper Sandler Reaffirms Their Sell Rating on Nutrien (NTR)
Stifel Nicolaus Remains a Buy on Nutrien (NTR)
Nutrien Announces Ken Seitz as a Speaker at the BMO Farm to Market Conference